Prandin (Repaglinide) for Diabetes | DiabetesTeam

Connect with others who understand.

sign up Log in
About DiabetesTeam
Powered By

Prandin is a prescription drug approved by the Food and Drug Administration (FDA) to help improve blood glucose control in adults with type 2 diabetes. Prandin is considered an adjunct treatment to diet and exercise. Prandin is also referred to by its drug name, Repaglinide.

Prandin is a meglitinide. Prandin is believed to work by increasing the amount of insulin released by the pancreas.

How do I take it?
Prescribing information states that Prandin is generally taken two, three, or four times a day with meals.

Prandin comes in tablet form.

Side effects
The FDA-approved label for Prandin lists common side effects including hypoglycemia (low blood sugar), back pain, flu-like symptoms, and dizziness.

Rare but serious side effects listed for Prandin include heart problems, blood disorders, and systemic allergic reactions.

Continue with Facebook
Continue with Google
Your privacy is our priority. By continuing, you accept our Terms of use and Privacy policy.
Already a Member? Log in